Patents by Inventor Francis Lyons

Francis Lyons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9042912
    Abstract: The disclosure includes a system and method for detecting fine grain copresence between users. The system includes a processor and a memory storing instructions that when executed cause the system to: process one or more signals to determine coarse grain location information of a first device and a second device; determine whether the first device and the second device are copresent based on the coarse grain location information; in response to determining that the first device and the second device are copresent based on the coarse grain location information, transmit a signal to the second device to alert the second device to listen for a fine grain copresence token from the first device; and refine copresence based on receiving an indication that the second device has received the fine grain copresence token.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: May 26, 2015
    Assignee: Google Inc.
    Inventors: Andrew Ames Bunner, Alan Lee Gardner, III, Mohammed Waleed Kadous, Brian Patrick Williams, Marc Stogaitis, Nadav Aharony, Brian Duff, Pascal Tom Getreuer, Zhentao Sun, Daniel Estrada Alva, Ami Patel, Benjamin Razon, Richard Daniel Webb, Tony Weber, Thomas Yuchin Chao, Ryan Michael Rifkin, Richard Francis Lyon, Liem Tran, Joseph A. Farfel
  • Publication number: 20150117599
    Abstract: We disclose an x-ray interferometric imaging system in which the x-ray source comprises a target having a plurality of structured coherent sub-sources of x-rays embedded in a thermally conducting substrate. The system additionally comprises a beam-splitting grating G1 that establishes a Talbot interference pattern, which may be a ? phase-shifting grating, and an x-ray detector to convert two-dimensional x-ray intensities into electronic signals. The system may also comprise a second analyzer grating G2 that may be placed in front of the detector to form additional interference fringes, and a means to translate the second grating G2 relative to the detector. In some embodiments, the structures are microstructures with lateral dimensions measured on the order of microns, and with a thickness on the order of one half of the electron penetration depth within the substrate. In some embodiments, the structures are formed within a regular array.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Inventors: Wenbing Yun, Sylvia Jia Yun Lewis, Janos Kirz, Alan Francis Lyon
  • Publication number: 20150110252
    Abstract: We disclose a compact source for high brightness x-ray generation. The higher brightness is achieved through electron beam bombardment of multiple regions aligned with each other to achieve a linear accumulation of x-rays. This may be achieved by aligning discrete x-ray sources, or through the use of novel x-ray targets that comprise a number of microstructures of x-ray generating materials fabricated in close thermal contact with a substrate with high thermal conductivity. This allows heat to be more efficiently drawn out of the x-ray generating material, and in turn allows bombardment of the x-ray generating material with higher electron density and/or higher energy electrons, leading to greater x-ray brightness. The orientation of the microstructures allows the use of an on-axis collection angle, allowing the accumulation of x-rays from several microstructures to be aligned to appear to have a single origin, also known as “zero-angle” x-ray emission.
    Type: Application
    Filed: September 19, 2014
    Publication date: April 23, 2015
    Inventors: Wenbing Yun, Sylvia Jia Yun Lewis, Janos Kirz, Alan Francis Lyon
  • Patent number: 8916552
    Abstract: The invention provides combinations comprising (or consisting essentially of) one or more ancillary compound(s) and a compound of the formula (I): or salts, tautomers, solvates and N-oxides thereof; wherein R1 is hydroxy or hydrogen; R2 is hydroxy; methoxy or hydrogen; provided that at least one of R1 and R2 is hydroxy; R3 is selected from hydrogen; halogen; cyano; optionally substituted C1-5 hydrocarbyl and optionally substituted C1-5 hydrocarbyloxy; R4 is selected from hydrogen; a group —(O)n—R7 where n is 0 or 1 and R7 is an optionally substituted acyclic C1-5 hydrocarbyl group or a monocyclic carbocyclic or heterocyclic group having 3 to 7 ring members; halogen; cyano; hydroxy; amino; and optionally substituted mono- or di-C1-5 hydrocarbyl-amino; or R3 and R4 together form a monocyclic carbocyclic or heterocyclic ring of 5 to 7 ring members; and NR5R6 forms an optionally substituted bicyclic heterocyclic group having 8 to 12 ring members of which up to 5 ring members are heteroatoms selected from oxyg
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: December 23, 2014
    Assignee: Astex Therapeutics Limited
    Inventors: Neil James Gallagher, John Francis Lyons, Neil Thomas Thompson, Stephen Murray Yule, Christopher William Murray
  • Patent number: 8883790
    Abstract: The invention provides combinations comprising (or consisting essentially of) one or more ancillary compound(s) and a compound of the formula (I): or salts, tautomers, solvates and N-oxides thereof; wherein R1 is hydroxy or hydrogen; R2 is hydroxy; methoxy or hydrogen; provided that at least one of R1 and R2 is hydroxy; R3 is selected from hydrogen; halogen; cyano; optionally substituted C1-5 hydrocarbyl and optionally substituted C1-5 hydrocarbyloxy; R4 is selected from hydrogen; a group —(O)n—R7 where n is 0 or 1 and R7 is an optionally substituted acyclic C1-5 hydrocarbyl group or a monocyclic carbocyclic or heterocyclic group having 3 to 7 ring members; halogen; cyano; hydroxy; amino; and optionally substituted mono- or di-C1-5 hydrocarbyl-amino; or R3 and R4 together form a monocyclic carbocyclic or heterocyclic ring of 5 to 7 ring members; and NR5R6 forms an optionally substituted bicyclic heterocyclic group having 8 to 12 ring members of which up to 5 ring members are heteroatoms selected from oxyg
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: November 11, 2014
    Assignee: Astex Therapeutics Limited
    Inventors: Neil James Gallagher, John Francis Lyons, Neil Thomas Thompson, Stephen Murray Yule, Christopher William Murray
  • Publication number: 20140221394
    Abstract: The invention provides an acid addition salt of a compound of the formula (1). Also provided by the invention are processes for preparing the compound of formula (1) and alkyl analogues thereof, novel intermediates for use in the process and methods for preparing the intermediates. The invention also provides new medical uses of compounds of the formula (1) and its ethyl analogue.
    Type: Application
    Filed: January 7, 2014
    Publication date: August 7, 2014
    Applicant: Astex Therapeutic Ltd.
    Inventors: Martyn Frederickson, John Francis Lyons, Neil Thomas Thompson, Mladen Vinkovic, Brian John Williams, Andrew James Woodhead, Alison Jo-Anne Woolford
  • Patent number: 8779132
    Abstract: The invention provides a compound for use in medicine, the compound being a compound of the formula (VI0) or a salt, solvate, tautomer or N-oxide thereof: wherein the bicyclic group: is selected from the structures C1, C5 and C6: wherein n is 0, 1, 2 or 3; R1 is hydrogen, hydroxy, or O—Rz; R2a is hydroxy, methoxy or O—Rz; provided that at least one of R1 and R2a is O—Rz; Rz is Lp-Rp1; SO3H; a glucuronide residue; a mono-, di- or tripeptide residue; or Lp is a bond, C?O, (C?O)O, (C?O)NRp1 or S(O)xNRp1; x is 1 or 2; Rp1 is hydrogen or a an optionally substituted C1-25 hydrocarbyl group containing 0, 1 or 2 carbocyclic rings and 0, 1, 2, 3, 4, 5 or 6 carbon-carbon multiple bonds, provided that Rp1 is not hydrogen when Lp is a bond, C?O or (C?O)O; and provided also that O—Rz does not contain an O—O moiety; and excluding compounds wherein R1 is hydroxy and R2a is methoxy; Rp2 and Rp3 are the same or different and each is a group Rp1; and R3, R4a, R8 and R10 are defined in the claims.
    Type: Grant
    Filed: October 12, 2007
    Date of Patent: July 15, 2014
    Assignee: Astex Therapeutics Limited
    Inventors: Miles Stuart Congreve, Lynsey Helen Fazal, Martyn Frederickson, Christopher William Murray, Michael Alistair O'Brien, Andrew James Woodhead, John Francis Lyons, Neil Thomas Thompson
  • Patent number: 8766090
    Abstract: The present invention relates to cost effective methods for metallization and or metallization and interconnection of high efficiency silicon based back-contacted back-junction solar panels and solar panels thereof having a multiplicity of alternating rectangular emitter- and base regions on the back-side of each cell, each with rectangular metallic electric finger conductor above and running in parallel with the corresponding emitter- and base region, a first insulation layer in-between the wafer and finger conductors, and a second insulation layer in between the finger conductors and cell interconnections.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: July 1, 2014
    Assignee: Rec Solar Pte. Ltd.
    Inventors: Richard Hamilton Sewell, Alan Francis Lyon, Andreas Bentzen
  • Patent number: 8736706
    Abstract: Methods and systems for generating high resolution composite imagery are provided. The methods and systems can create a fully-in-focus high resolution composite image by combining a number of source images in which only a part of the source image is in-focus. The composite image can be analyzed to identify portions of the composite image that satisfy an image quality metric. The capture of additional source images can be controlled based at least in part on the image analysis of the composite image. In addition, a control routine for capturing the plurality of source images can be dynamically adjusted based on the image quality of the individual source images.
    Type: Grant
    Filed: March 13, 2012
    Date of Patent: May 27, 2014
    Assignee: Google Inc.
    Inventors: Matthew Thomas Valente, Richard Francis Lyon, Peter Gregory Brueckner
  • Patent number: 8737565
    Abstract: A compound zone plate comprising a first zone plate frame including a first zone plate, a second zone plate frame including a second zone plate, and a base frame to which the first zone plate frame and the second zone plate frame are bonded. In examples, two more zone plates are added to make a four element optic. In the assembly process, the microbeads are used to ensure the parallelism, dial in the distance precisely between the zone plates by selecting the microbead size, possibly in response to the width of the frames, and ensure low friction lateral movement enabling nanometer precision alignment of the zone plates with respect to each other prior to being fixed by the adhesive. That is, when the frames are pressed together to ensure parallelism, it is still possible to align them to each other since the microbead layer facilitates the inplane movement of the alignment process.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: May 27, 2014
    Assignee: Carl Zeiss X-Ray Microscopy, Inc.
    Inventors: Alan Francis Lyon, Michael Feser, Wenbing Yun, Sharon Chen
  • Publication number: 20140126703
    Abstract: A compound x-ray lens and method of fabricating these lenses are disclosed. These compound lenses use multiple zone plate stacking to achieve a pitch frequency increase for the resulting combined zone plate. The compound equivalent zone plate includes a first zone plate having an initial pitch frequency stacked onto a second zone plate to form an equivalent compound zone plate. The equivalent zone plate has a pitch frequency that is at least twice the initial pitch frequency. Also, in one example, the equivalent zone plate has a mark-to-space ratio of 1:1.
    Type: Application
    Filed: October 31, 2013
    Publication date: May 8, 2014
    Inventors: Michael Feser, Alan Francis Lyon
  • Patent number: 8705320
    Abstract: Systems and methods for providing audio localization are provided. In some aspects, a method includes receiving phase offsets of a plurality of fixed transmitters from a source other than the plurality of fixed transmitters, detecting an audio localization signal from each of the plurality of fixed transmitters, determining a received phase of the audio localization signal from each of the plurality of fixed transmitters, determining time differences of flight from the mobile receiver to the plurality of fixed transmitters using the received phases, determining distance differences from the mobile receiver to the plurality of fixed transmitters using the time differences of flight, and determining the location of the mobile receiver by performing multilateration using the distance differences.
    Type: Grant
    Filed: September 13, 2012
    Date of Patent: April 22, 2014
    Assignee: Google Inc.
    Inventors: Jason Holt, Richard Francis Lyon
  • Publication number: 20130338806
    Abstract: Systems and techniques for removing a sound recording from an audio recording (e.g., an audio recording embedded in a media file) are presented. The system can include an identification component, a first subtraction component and a second subtraction component. The identification component identifies a sound recording in a mixed audio recording. The first subtraction component determines a local linear transformation of the sound recording and subtracts the local linear transformation of the sound recording from the mixed audio recording to generate a new mixed audio recording. The second subtraction component compares one or more segments of the sound recording with one or more corresponding segments of the new mixed audio recording and reduces a power level of the new mixed audio recording based at least in part on correlation of the one or more corresponding segments with the one or more segments.
    Type: Application
    Filed: December 28, 2012
    Publication date: December 19, 2013
    Applicant: GOOGLE INC.
    Inventors: Christopher Russell LaRosa, Sam Kvaalen, Thomas Chadwick Walters, Richard Francis Lyon, Robert Steven Glickstein, Rushabh Ashok Doshi, Molly Castle Nix, Jason Matthew Toff
  • Patent number: 8541461
    Abstract: The invention provides a combination comprising an ancillary compound (e.g.
    Type: Grant
    Filed: June 21, 2006
    Date of Patent: September 24, 2013
    Assignees: Astex Therapeutics Limited, The Institute of Cancer Research Royal Cancer Hospital, Cancer Research Technology Limited
    Inventors: Neil Thomas Thompson, Robert George Boyle, Ian Collins, Michelle Dawn Garrett, John Francis Lyons, Kyla Merriom Thompson
  • Publication number: 20130240022
    Abstract: The present invention relates to cost effective production methods of high efficiency silicon based back-contacted back-junction solar panels and solar panels thereof having a multiplicity of alternating rectangular emitter- and base regions on the back-side of each cell, each with rectangular metallic electric finger conductor above and running in parallel with the corresponding emitter- and base region, a first insulation layer in-between the wafer and finger conductors, and a second insulation layer in between the finger conductors and cell interconnections.
    Type: Application
    Filed: September 28, 2012
    Publication date: September 19, 2013
    Applicant: RENEWABLE ENERGY CORPORATION ASA
    Inventors: Richard Hamilton SEWELL, Andreas BENTZEN, Lawrence Frederick SCHLOSS, Young Seen LEE, Hiroaki HAYASHIGATANI, Toshio ITOH, Alan Francis LYON, Roger THOMPSON, Nemia GRUBISICH
  • Publication number: 20130240023
    Abstract: The present invention relates to cost effective methods for metallisation and or metallisation and interconnection of high efficiency silicon based back-contacted back-junction solar panels and solar panels thereof having a multiplicity of alternating rectangular emitter- and base regions on the back-side of each cell, each with rectangular metallic electric finger conductor above and running in parallel with the corresponding emitter- and base region, a first insulation layer in-between the wafer and finger conductors, and a second insulation layer in between the finger conductors and cell interconnections.
    Type: Application
    Filed: September 28, 2012
    Publication date: September 19, 2013
    Applicant: RENEWABLE ENERGY CORPORATION ASA
    Inventors: Richard Hamilton SEWELL, Alan Francis LYON, Andreas BENTZEN
  • Patent number: 8526575
    Abstract: A compound zone plate comprising a first zone plate frame including a first zone plate, a second zone plate frame including a second zone plate, and a base frame to which the first zone plate frame and the second zone plate frame are bonded. In examples, two more zone plates are added to make a four element optic. In the assembly process, the microbeads are used to ensure the parallelism, dial in the distance precisely between the zone plates by selecting the microbead size, possibly in response to the width of the frames, and ensure low friction lateral movement enabling nanometer precision alignment of the zone plates with respect to each other prior to being fixed by the adhesive. That is, when the frames are pressed together to ensure parallelism, it is still possible to align them to each other since the microbead layer facilitates the inplane movement of the alignment process.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: September 3, 2013
    Assignee: Xradia, Inc.
    Inventors: Alan Francis Lyon, Michael Feser, Wenbing Yun, Sharon Chen
  • Patent number: 8435970
    Abstract: The invention provides combinations of an ancillary compound and a compound which is a salt of 1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea selected from the lactate and citrate salts and mixtures thereof. Also provided are crystalline forms of the salts, methods for making the salts and their uses in treating cancers. The invention further provides combinations of an ancillary compound and a compound of the formula (I) as defined in PCT/GB2004/002824 (WO 2005/002552) or a compound of the formula (I?) or a salt, solvate, tautomer or N-oxide thereof, wherein R1, E, A and M are as defined in the claims.
    Type: Grant
    Filed: June 29, 2007
    Date of Patent: May 7, 2013
    Assignee: Astex Therapeutics Limited
    Inventors: Jayne Elizabeth Curry, Neil James Gallagher, John Francis Lyons, Neil Thomas Thompson
  • Patent number: 8404718
    Abstract: The invention provides a combination comprising a cytotoxic compound, a signalling inhibitor, an ancillary agent, or two or more further anti-cancer agents, and a compound having the formula (Ib): or salts or tautomers or N-oxides or solvates thereof; wherein X is a group R1-A-NR4—; A is a bond, C?O, NRg(C?O) or O(C?O) wherein Rg is hydrogen or C1-4 hydrocarbyl optionally substituted by hydroxy or C1-4 alkoxy; Y is a bond or an alkylene chain of 1, 2 or 3 carbon atoms in length; R1 is a carbocyclic or heterocyclic group having from 3 to 12 ring members; or a C1-8 hydrocarbyl group optionally substituted by one or more substituents selected from fluorine, hydroxy, C1-4 hydrocarbyloxy, amino, mono- or di-C1-4 hydrocarbylamino, and carbocyclic or heterocyclic groups having from 3 to 12 ring members, and wherein 1 or 2 of the carbon atoms of the hydrocarbyl group may optionally be replaced by an atom or group selected from O, S, NH, SO, SO2; R2 is hydrogen; halogen; C1-4 alkoxy (e.g.
    Type: Grant
    Filed: April 1, 2010
    Date of Patent: March 26, 2013
    Assignee: Astex Therapeutics Limited
    Inventors: Jayne Elizabeth Curry, John Francis Lyons, Matthew Simon Squires, Neil Thomas Thompson, Kyla Merriom Thompson, Paul Graham Wyatt
  • Patent number: 8399442
    Abstract: A method for the treatment of: A. a disease state or condition mediated by a kinase wh ich is BCR-abl, VEGFR, PDGFR, EGFR, FLT3, JAK, C-abl, PDK1, Chk, FGFR, Ret, Eph, or Src; or B. a cancer in which the cancer cells thereof contain a drug resistant kinase mutation which is: (a) a threonine gatekeeper mutation; or (b) a drug-resistant gatekeeper mutation; or (c) an imatinib resistant mutation; or (d) a nilotinib resistant mutation; or (e) a dasatinib resistant mutation; or (f) a T670l mutation in KIT; or (g) a T674l mutation in PDGFR; or (h) T790M mutation in EGFR; or (i) a T315l mutation in abl; or C. a cancer which expresses a mutated molecular target which is a mutated form of BCRabl, c-kit, PDGF, EGF receptor or ErbB2; which method comprises administering to a patient in need thereof a therapeutically effective amount of a compound of the formula (l or l?): or a salt, solvate, tautomer or N-oxide thereof.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: March 19, 2013
    Assignee: Astex Therapeutics Limited
    Inventors: Valerio Berdini, Jayne Elizabeth Curry, Neil James Gallagher, Adrian Liam Gill, John Francis Lyons